The pharmaceutical industry faces a stark reality: only about 12% of drug candidates that enter preclinical development eventually reach the market. Many of these failures are not because a drug lacks therapeutic potential, but because of unfavorable pharmacokinetic properties or unexpected toxicity.

Drug Metabolism and Pharmacokinetics (DMPK) is a cornerstone discipline in drug discovery, playing a critical role in determining whether a promising compound can successfully become a safe, effective medicine. Its importance lies in its power to predict how a drug will behave in the body and to eliminate "losers" early, saving significant time and resources.

In PharmaResources, we have been providing DMPK services to our clients worldwide for more a decade, and successfully helped our collaborators fastened their discovery process. Our services focusing on in vitro ADME, PK, Exploratory Toxicology, and Bioanalysis. We have internal animal resources, ranging from small rodents to dog and NHPs.